Thromboxane Biosynthesis and Platelet Function in Type II Diabetes Mellitus

New England Journal of Medicine

Volumn 322, Issue 25, 1990, Pages 1769-1774

  Davì, Giovanni ^a   Catalano, Isabella ^a   Averna, Maurizio ^a   Notarbartolo, Alberto ^a   Strano, Antonio ^b   Ciabattoni, Giovanni ^c   Patrono, Carlo ^c  

^a UNIVERSITY OF CHIETI   (Italy)

^b Catholic University School of Medicine ^*  (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; INSULIN; THROMBOXANE B2;

ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

EID: 0025282786     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199006213222503     Document Type: Article

References (26)

1. Mustard JF, Packham MA. Platelets and diabetes mellitus. N Engl J Med 1984; 311:665–7.
2. Di Minno G, Silver MJ, Cerbone AM, et al. Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. Blood 1985; 65:156–62.
3. Alessandrini P, McRae J, Feman S, FitzGerald GA. Thromboxane biosynthesis and platelet function in Type I diabetes mellitus. N Engl J Med 1988; 319:208–12.
4. Davì G, Rini GB, Averna M, et al. Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabetics. Thromb Res 1982; 26:359–70.
5. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039–57.
6. Roberts LJ, Sweetman BJ, Oates JA. Metabolism of thromboxane B2 in man: identification of twenty urinary metabolites. J Biol Chem 1981; 256:8384–93.
7. Estimated rate of thromboxane secretion into the circulation of normal humans, C., Patrono, G., Ciabattoni, F., Pugliese, A., Pierucci, I.A., Blair, G.A., FitzGerald, J Clin Invest, (1986), 77, 590-594
8. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194:927–9.
9. Ciabattoni G, Maclouf J, Catella F, FitzGerald GA, Patrono C. Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine. Biochim Biophys Acta 1987; 918:293–7.
10. Curtiss LK, Witztum JL. A novel method for generating region-specific monoclonal antibodies to modified proteins: application to the identification of human glycosylated low density lipoproteins. J Clin Invest 1983; 72:1427–38.
11. Siegel S. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill, 1956:184.
12. Ciabattoni G, Pugliese F, Davì G, Pierucci A, Simonetti BM, Patrono C. Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man. Biochim Biophys Acta 1989; 992:66–70.
13. Burch JW, Stanford N, Majerus PW. Inhibition of platelet prostaglandin synthetase by oral aspirin. J Clin Invest 1978; 61:314–9.
14. Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 1982; 69:1366–72.
15. Colwell JA, Winocour PD, Lopes-Virella M, Halushka PV. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med 1983; 75: Suppl 5B:67–80.
16. Halushka PV, Rogers RC, Loadhold CB, Colwell JA. Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med 1981; 97:87–96.
17. Butkus A, Skrinska VA, Schumacher OP. Thromboxane production and platelet aggregation in diabetic subjects with clinical complications. Thromb Res 1980; 19:211–23.
18. FitzGerald GA, Pedersen AK, Patrono C. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. Circulation 1983; 67:1174–7.
19. Patrono C, Ciabattoni G, Patrignani P. Biochemical indices of arachidonate metabolism by platelets and vascular endothelium in vivo. In: Patrono C, FitzGerald GA, eds. Platelets and vascular occlusion. New York: Raven Press, 1989:193–212.
20. Patrono C, Ciabattoni G, Remuzzi G, et al. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. J Clin Invest 1985; 76:1011–8.
21. Catella F, FitzGerald GA. Paired analysis of urinary thromboxane B2 metabolites in humans. Thromb Res 1987; 47:647–56.
22. Fitzgerald DJ, Roy L, Catella F, FitzGerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315:983–9.
23. Vejar M, Fragasso G, Hackett D, et al. Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina. Thromb Haemost 1990; 63:163–8.
24. Mayfield RK, Halushka PV, Wohltmann HJ, et al. Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients. Diabetes 1985; 34:1127–33.
25. Davì G, Averna M, Catalano I, et al. Platelet function in patients with type 2 diabetes mellitus: the effect of glycaemic control. Diabetes Res 1989; 10:7–12.
26. Le Pape A, Gutman N, Guitton JD, Legrand Y, Muh JP. Non enzymatic glycosylation increases platelet aggregating potency of collagen from placenta of diabetic human beings. Biochem Biophys Res Commun 1983; 111:602–10.